Talking about IoT in medical technology does not simply mean adding connectivity to devices. It means recognising a deeper transformation in how electromedical products are conceived, used and valued over time.
In the medical field, IoT takes shape through intelligent systems equipped with sensing capabilities, actuation functions and communication features. These products are designed to support diagnostic, therapeutic and remote monitoring activities. They do not operate as standalone objects, but as part of a regulated clinical ecosystem where reliability, continuity and trust are essential.
Connectivity, trust and certifiability
When telemedicine enters the picture, data becomes central. The collection and transmission of clinical data introduce a level of responsibility that goes far beyond technical performance.
Privacy and reliability are not optional attributes. They are necessary conditions for a medical IoT device to be certifiable. Although these systems do not follow the formal functional safety frameworks typical of sectors such as railway, they are fully mission critical. Data integrity and functional reliability have a direct impact on patient safety and outcomes.
For this reason, a medical IoT solution cannot be treated as an advanced consumer product. It must be designed as a clinical system capable of guaranteeing operational continuity, secure data handling and consistent performance over time.
From product logic to service logic
The objective of IoT in medical technology is clear: collecting data, sharing it and transforming it into value.
In this scenario, the value of a device no longer lies in its standalone functionality. It lies in its ability to generate meaningful information over time. The value proposition shifts accordingly, moving from product to service.
The device becomes a means to collect data that is transferred to the cloud and processed through models, data analytics and artificial intelligence. This is where the Product as a Service concept takes shape. The service is not the physical device itself, but what its data enables in terms of insights, decisions and long-term value, including from a business perspective.
Data as an enabler of personalised care
Diabetes diagnostics offer a clear illustration of this transition. Traditionally, therapy management relied on spot measurements taken once or twice a day. Each measurement provided a useful but limited snapshot.
Over time, this approach evolved into continuous monitoring systems based on wearable devices capable of measuring glucose levels continuously. Early solutions allowed data consultation at intervals, while more recent generations introduced permanent connectivity to mobile devices and cloud platforms.
The result is a fundamental change. Data is no longer a collection of isolated points, but a continuous profile that describes the patient’s trend over time. This profile enables correlations with external factors such as diet or physical activity and supports more precise therapeutic interventions.
In this context, IoT delivers tangible value to patients by enabling personalised care built on the real evolution of individual data.
From observation to closed-loop systems
Looking at projects currently under development, a clear growth in IoT platforms focused on data valorisation is emerging. From Eletech’s perspective, Head of the International Design Centres, R&D division of the Group, gained through close collaboration with customers on initiatives expected to reach the market within the next few years, the direction is evident.
Systems are becoming more integrated, more intelligent and more autonomous. The vision of the artificial pancreas is a concrete example of this trajectory.
Today, many solutions still operate as partially closed-loop systems, where sensors collect data, cloud platforms process it and human users intervene to adjust therapy. The human remains part of the loop.
The future objective is to remove this mediation. Implanted systems will be able to measure, decide and act autonomously, releasing insulin and maintaining glucose levels within optimal ranges under varying conditions. A behaviour that increasingly resembles that of a biological organ.
This evolution is made possible by the growing availability of data and by increasingly accurate models capable not only of describing current conditions, but also of anticipating system behaviour and supporting more advanced decision-making.
Looking ahead
As a global leader in mechatronics for a wide range of high-tech sectors, including advanced Medical and Healthcare, Elemaster Group contributes to shaping this transformation.
The Group looks forward to meeting partners and professionals at World Health Expo 2026, taking place in Dubai from 9 February. The international team will be available in Hall North 21, Booth F113, to share its expertise and discuss how electronics and system integration are shaping the healthcare technologies of tomorrow.